MX2016005263A - Composiciones activables para la liberacion controlada en dos etapas de sustancias quimicas proactivas. - Google Patents

Composiciones activables para la liberacion controlada en dos etapas de sustancias quimicas proactivas.

Info

Publication number
MX2016005263A
MX2016005263A MX2016005263A MX2016005263A MX2016005263A MX 2016005263 A MX2016005263 A MX 2016005263A MX 2016005263 A MX2016005263 A MX 2016005263A MX 2016005263 A MX2016005263 A MX 2016005263A MX 2016005263 A MX2016005263 A MX 2016005263A
Authority
MX
Mexico
Prior art keywords
functional active
active substance
ester
controlled release
trigonellin
Prior art date
Application number
MX2016005263A
Other languages
English (en)
Other versions
MX353460B (es
Inventor
Song Xuedong
Weng Yiming
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of MX2016005263A publication Critical patent/MX2016005263A/es
Publication of MX353460B publication Critical patent/MX353460B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8182—Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/01—Deodorant compositions
    • A61L9/012—Deodorant compositions characterised by being in a special form, e.g. gels, emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00—Essential oils; Perfumes
    • C11B9/0007—Aliphatic compounds
    • C11B9/0015—Aliphatic compounds containing oxygen as the only heteroatom
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00—Essential oils; Perfumes
    • C11B9/0026—Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring
    • C11B9/003—Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring the ring containing less than six carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00—Essential oils; Perfumes
    • C11B9/0061—Essential oils; Perfumes compounds containing a six-membered aromatic ring not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/548—Associative polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

Una composición activable para la liberación controlada en dos etapas de una sustancia química activa funcional incluye un éster de trigonelina de una sustancia activa funcional con al menos un grupo hidroxilo que se configura para liberar la sustancia activa funcional a través de una reacción de hidrólisis tras el contacto con un medio acuoso, y un material de encapsulación para encapsular el éster de trigonelina que incluye una sustancia activa funcional, el material de encapsulación es activable para liberar el éster de trigonelina tras la ocurrencia de un estímulo ambiental. En otros aspectos, un líquido viscoso o un artículo absorbente incluye una composición activable para la liberación controlada en dos etapas de una sustancia química activa funcional, la composición incluye un éster de trigonelina de una sustancia activa funcional con al menos un grupo hidroxilo que se configura para liberar la sustancia activa funcional a través de una reacción de hidrólisis tras el contacto con un medio acuoso, y un material de encapsulación para encapsular el éster de trigonelina que incluye una sustancia activa funcional.
MX2016005263A 2013-10-30 2014-10-14 Composiciones activables para la liberación controlada en dos etapas de sustancias químicas proactivas. MX353460B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/066,856 US9119780B2 (en) 2013-10-30 2013-10-30 Triggerable compositions for two-stage, controlled release of proactive chemistry
PCT/IB2014/065311 WO2015063638A1 (en) 2013-10-30 2014-10-14 Triggerable compositions for two-stage, controlled release of proactive chemistry

Publications (2)

Publication Number Publication Date
MX2016005263A true MX2016005263A (es) 2016-08-18
MX353460B MX353460B (es) 2018-01-12

Family

ID=52995728

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016005263A MX353460B (es) 2013-10-30 2014-10-14 Composiciones activables para la liberación controlada en dos etapas de sustancias químicas proactivas.

Country Status (7)

Country Link
US (1) US9119780B2 (es)
KR (1) KR101732326B1 (es)
AU (1) AU2014343312B2 (es)
BR (1) BR112016009187B1 (es)
GB (1) GB2535098B (es)
MX (1) MX353460B (es)
WO (1) WO2015063638A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109153639B (zh) * 2016-03-14 2022-07-29 斯法尔制药私人有限公司 葫芦巴碱类化合物
JP2023553010A (ja) 2020-12-03 2023-12-20 バテル・メモリアル・インスティテュート 非ウイルス性送達のためのポリマーナノ粒子およびｄｎａナノ構造組成物ならびに方法
EP4320233A4 (en) 2021-04-07 2025-08-13 Battelle Memorial Institute RAPID DESIGN, BUILD, TEST, AND LEARNING TECHNOLOGIES TO IDENTIFY AND USE NON-VIRAL VECTORS
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
WO2025122954A1 (en) 2023-12-08 2025-06-12 Battelle Memorial Institute Use of dna origami nanostructures for molecular information based data storage systems

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4020156A (en) 1976-02-13 1977-04-26 Norda Incorporated Controlled fragrance releasing crystal beads
US4880921A (en) 1982-05-18 1989-11-14 University Of Florida Brain-specific drug delivery
US4540564A (en) 1982-05-18 1985-09-10 University Of Florida Brain-specific drug delivery
JP2775154B2 (ja) 1988-04-26 1998-07-16 株式会社資生堂 肌荒れ防止剤および老化防止剤
US5130290A (en) 1989-03-27 1992-07-14 Kanzaki Paper Manufacturing Co., Ltd. Water-sensitive coloring sheet
US5133958A (en) 1989-04-20 1992-07-28 Erwin Stuckler Agent for nail, skin and hair care
JPH03221039A (ja) 1990-01-26 1991-09-30 Kanzaki Paper Mfg Co Ltd 紙おむつ
US5197958A (en) 1992-04-01 1993-03-30 Howell Wesley A Wetness indicating diaper
US5622944A (en) 1992-06-12 1997-04-22 Affymax Technologies N.V. Testosterone prodrugs for improved drug delivery
EP0752465A1 (en) 1995-06-01 1997-01-08 The Procter & Gamble Company Betaine esters for delivery of alcohols
PT771785E (pt) 1995-11-02 2002-06-28 Procter & Gamble Compostos aminoester de alcoois perfumados e seu uso em composicoes de limpeza ou lavandaria
US5958870A (en) 1996-04-01 1999-09-28 The Procter & Gamble Company Betaine ester compounds of active alcohols
JP2000505692A (ja) 1996-12-17 2000-05-16 ザ、プロクター、エンド、ギャンブル、カンパニー 臭気制御システムを有する吸収製品
US5827913A (en) 1997-02-05 1998-10-27 H.B. Fuller Licensing & Financing, Inc. Hot melt adhesive comprising an encapsulated ingredient
DE19818044A1 (de) 1998-04-22 1999-10-28 Klinge Co Chem Pharm Fab Verwendung von Vitamin-PP-Verbindungen
AU4025800A (en) 1999-03-22 2000-10-09 Ideation International, Inc. Composite fiber for absorptive material construction
DE19948667A1 (de) 1999-10-08 2001-04-12 Henkel Kgaa Reinigungsmittelkomponente mit doppelkontrollierter Duftfreisetzung
DE60023931T2 (de) 1999-10-18 2006-08-03 Firmenich S.A. Ester mit einer sekundären carbamoylgruppe und deren verwendung als ausgangsstoffe von duftenden alkoholen
JP3853549B2 (ja) 1999-11-10 2006-12-06 花王株式会社 機能性アルコール放出物質
US6369290B1 (en) 2000-02-17 2002-04-09 Tyco Healthcare Retail Services Ag Time release odor control composition for a disposable absorbent article
US7758888B2 (en) * 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
WO2001085081A1 (en) 2000-05-09 2001-11-15 The Procter & Gamble Company Composite fabric panel for disposable absorbent articles
EP1203578A1 (en) * 2000-11-03 2002-05-08 The Procter & Gamble Company Methods and compositions for improved fragrancing of a surface
AU2002339696A1 (en) 2001-12-03 2003-06-17 Genset S.A. Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase inhibitors
DE10217705A1 (de) 2002-04-20 2003-11-06 Goldschmidt Ag Th Wäscheweichspülformulierungen enthaltend Betainesterderivate sowie Verfahren zur Verbesserung der Waschleistung von Waschmitteln
CA2489071A1 (en) 2002-07-04 2004-01-15 Janssen Pharmaceutica N.V. Solid dispersions comprising two different polymer matrixes
US7670627B2 (en) 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
DE60315241T2 (de) 2002-12-09 2008-04-17 Rohm And Haas Co. Zusammensetzungen mehrstufiger Polymere mit ausgelöster Freisetzung
US8409618B2 (en) 2002-12-20 2013-04-02 Kimberly-Clark Worldwide, Inc. Odor-reducing quinone compounds
WO2004091601A1 (fr) 2003-04-17 2004-10-28 Jallal Messadek Formulations orales flottantes pour la liberation controlee de la betaine
AU2003239845A1 (en) 2003-05-07 2004-11-26 Ifac Gmbh And Co.Kg Compositions for the targetted release of fragrances and aromas
SE0302924D0 (sv) 2003-11-05 2003-11-05 Camurus Ab Pharmaceutical composition having a cationic excipient
DE102004013798A1 (de) 2004-03-20 2005-10-06 Wella Aktiengesellschaft Verwendung von Mitteln zur kosmetischen Behandlung von Keratin enthaltenden Material
ES2368062T3 (es) 2004-04-30 2011-11-14 The Procter & Gamble Company Artículo absorbente que cambia de color.
EP1624002B1 (en) 2004-08-07 2019-04-03 The Procter & Gamble Company Superabsorbent polymer particles comprising functionalizers and method of making them
FR2880884B1 (fr) 2005-01-19 2007-04-20 Mane Fils Sa V Nouveaux composes odorants, procede de synthese et utilisations
CA2614577A1 (en) 2005-06-09 2006-12-14 Evonik Degussa Gmbh Fragrance alcohol-releasing polysiloxane
WO2007038966A1 (en) 2005-10-05 2007-04-12 Sca Hygiene Products Ab Absorbent article comprising a thin film including an active agent
US20070105793A1 (en) 2005-11-04 2007-05-10 Curt Hendrix Compositions and methods using nicotinic acid for treatment of hypercholesterolemia, hyperlipidemia nd cardiovascular disease
US20070270773A1 (en) 2006-05-16 2007-11-22 Suzan Delain Mackey Absorbent articles and garments with thermochromic wetness indicator(s)
GB2458032A (en) 2006-09-27 2009-09-09 Luvgear Inc Device and method for identifying a change in a predetermined condition
JP5371766B2 (ja) 2006-10-10 2013-12-18 フイルメニツヒ ソシエテ アノニム 活性分子の制御放出のためのポリマー結合体
JP5345940B2 (ja) 2006-10-20 2013-11-20 ネステク ソシエテ アノニム 排泄物捕集マット
US20080139378A1 (en) 2006-12-07 2008-06-12 Degussa Ag Urine-absorbing composition with fragrance release upon use
CA2679206C (en) 2007-03-05 2015-02-24 Indus Biotech Private Limited Pharmaceutical compositions comprising trigonelline and 4-hydroxyisoleucine and a process thereof
US8029190B2 (en) 2007-05-10 2011-10-04 Kimberly-Clark Worldwide, Inc. Method and articles for sensing relative temperature
EP1992366B1 (en) 2007-05-15 2011-07-06 The Procter & Gamble Company Use of a lotion composition on an absorbent article for reducing adherence of feces or menses to the skin
US7550416B2 (en) 2007-06-27 2009-06-23 The Procter & Gamble Company Perfumed household products and methods for preserving perfume integrity and extending fragrance life
WO2009018368A1 (en) 2007-07-30 2009-02-05 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Combination treatment of nmda (n-methyl-d-aspartate)-enhancer, glycine transporter inhibitor, d-amino acid oxidase inhibitor (daaoi) for neuropsychiatric disorders
EP2184175B1 (en) 2007-08-29 2015-05-20 Nippon Paper Industries Co., Ltd. Thermal recording medium
US20090156634A1 (en) 2007-12-12 2009-06-18 Iovate T. & P. Inc. Tropane alkaloids and trigonelline combinations and methods for administering the same
US8497409B2 (en) 2008-02-29 2013-07-30 Kimberly-Clark Worldwide, Inc. Absorbent article having an olfactory wetness signal
WO2009144696A1 (en) 2008-04-15 2009-12-03 Joshua Waldhorn An absorbing and saturation detection pad and methods thereof
US20090275908A1 (en) 2008-04-30 2009-11-05 Kimberly-Clark Worldwide, Inc. Absorbent Articles Capable of Indicating the Presence of Urine
KR20110000580A (ko) 2008-06-25 2011-01-03 교도 인사쯔 가부시키가이샤 습도 지시기와 그 제조 방법
US9554948B2 (en) 2008-07-30 2017-01-31 Kimberly-Clark Worldwide, Inc. Absorbent products with wetness sensors
TWI404544B (zh) 2008-08-11 2013-08-11 美國棕欖公司 含珠粒之口腔保健組成物
WO2010039861A2 (en) 2008-09-30 2010-04-08 The Regents Of The University Of Michigan Dendrimer conjugates
US20100191205A1 (en) 2009-01-29 2010-07-29 Sca Hygiene Products Ab Opening system for absorbent articles
EP2440206B1 (en) 2009-06-11 2018-07-18 DSM IP Assets B.V. Trigonellin as a muscle stimulant
US9265856B2 (en) 2009-07-15 2016-02-23 Kimberly-Clark Worldwide Inc. Multiple component materials having a color-changing composition
CA2777682C (en) 2009-10-13 2015-02-24 The Regents Of The University Of Michigan Dendrimer compositions and methods of synthesis
US8697003B2 (en) 2009-12-14 2014-04-15 Kimberly-Clark Worldwide, Inc. Aqueous-triggered color-appearing inks
US8557894B2 (en) 2009-12-17 2013-10-15 Kimberly-Clark Worldwide, Inc. Water-triggered coloring or color changing indicator
ES2645015T3 (es) 2010-04-07 2017-12-01 Kemin Industries, Inc. Micropartículas para la administración oral en animales
US20120064136A1 (en) 2010-09-10 2012-03-15 Nanobio Corporation Anti-aging and wrinkle treatment methods using nanoemulsion compositions
LT2661266T (lt) 2011-01-07 2020-12-10 Anji Pharma (Us) Llc Gydimo būdai chemosensorinio receptoriaus ligando pagrindu
US9326932B2 (en) 2011-07-25 2016-05-03 Us Cosmeceutechs, Llc Botanical antioxidant compositions and methods of preparation and use thereof
US8791045B2 (en) * 2011-11-09 2014-07-29 Kimberly-Clark Worldwide, Inc. Non-tacky wetness indicator composition for application on a polymeric substrate

Also Published As

Publication number Publication date
BR112016009187B1 (pt) 2020-11-03
GB2535098A (en) 2016-08-10
GB2535098B (en) 2020-09-23
GB201609169D0 (en) 2016-07-06
AU2014343312B2 (en) 2017-11-09
MX353460B (es) 2018-01-12
WO2015063638A1 (en) 2015-05-07
AU2014343312A1 (en) 2016-06-02
KR20160070101A (ko) 2016-06-17
US20150118294A1 (en) 2015-04-30
US9119780B2 (en) 2015-09-01
KR101732326B1 (ko) 2017-05-02

Similar Documents

Publication Publication Date Title
MX2016005263A (es) Composiciones activables para la liberacion controlada en dos etapas de sustancias quimicas proactivas.
CO2019005729A2 (es) Preparación de complejos sólidos de ciclodextrina para suministro de ingredientes farmacéuticos activos oftálmicos
CO6602159A2 (es) Formulaciones de aceite que comprenden compuestos de ciclopropeno
CL2016000882A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15).
MX2016009095A (es) Proceso para preparar microcapsulas aminoplasticas.
AR085665A1 (es) Fluidos de tratamiento que contienen un agente quelante biodegradable y metodos para su uso
CL2012001682A1 (es) Composición antitranspirante anhidra líquida que comprende a) un vehículo e la forma de un disolvente eutectico profundo, que comprende i) al menos un miembro elegido de un catión y de un ion anfotero y ii) un donador de enlace de hidrógeno y b) al menos un ingrediente activo antitranspirante; un método de uso de la composición.
CR20140365A (es) Compuestos de carbamato y preparación y uso de los mismos
MX2015017501A (es) Composicion para el cuidado bucal antimanchas.
BRPI1003281A2 (pt) Composição e método para maquilar um substrato queratínico
CO2018010694A2 (es) Una composición de componente único o múltiple para la producción de un hidrogel
CR20120140A (es) Composiciones de liberación controlada
MX348807B (es) Composiciones activables para la liberacion controlada en dos etapas de sustancias quimicas activas.
MX2016007134A (es) Composiciones farmaceuticas mejoradas de pimobendan.
ECSP17057364A (es) Encapsulado de agentes activos de alta potencia
EA201390612A1 (ru) Биоразлагаемая композиция для доставки лекарственного средства
BR112016014870A2 (pt) Formulação de selante líquido compreendendo monômeros de fibrina e um peptídeo de gprp, seu método de fabricação, recipiente e kit
EA201390412A1 (ru) Стабилизированная композиция такролимуса
BR112014001825A2 (pt) lenço para a aplicação de pelo menos um princípio ativo sobre a pele
CL2016001130A1 (es) Composiciones sólidas de triglicéridos y usos de estas
SV2014004796A (es) Composiciã“n de liberaciã“n controlada y mã‰todos para su uso
BR112015022975A8 (pt) Partículas de resinato de fenilefrina
CL2011000102A1 (es) Composicion de vidriado para su aplicacion a un sustrato quecomprende latex en polvo seco, emulsion de latex liquida, disolvente coalescente, cera, espesante y agua, opcionalmente puede utilizarse un agente dispersante.
BR112013008029A2 (pt) método e composição para passivar uma superfície metálica, uso de uma composição, e, revestimento em uma superfície metálica
PH12014501307A1 (en) Liquid activation system

Legal Events

Date Code Title Description
FG Grant or registration